Impact of COVID-19 vaccination: a global perspective

Impact of COVID-19 vaccination: a global perspective

IntroductionThe COVID-19 pandemic has caused widespread morbidity, mortality, and socio-economic disruptions worldwide. Vaccination has proven to be a crucial strategy in controlling the spread of the virus and mitigating its impact.ObjectiveThe study focuses on assessing the effectiveness of COVID-...

Full description

Bibliographic Details
Main Authors:	Priya Singh, Aditya Anand, Shweta Rana, Amit Kumar, Prabudh Goel, Sujeet Kumar, Krushna Chandra Gouda, Harpreet Singh
Format:	Article
Language:	English
Published:	Frontiers Media S.A. 2024-01-01
Series:	Frontiers in Public Health
Subjects:	COVID-19 vaccination positivity rate hospitalization delta variant
Online Access:	https://www.frontiersin.org/articles/10.3389/fpubh.2023.1272961/full

Similar Items

Impact of comorbidity on patients with COVID-19 in India: A nationwide analysis
by: Priya Singh, et al.
Published: (2023-01-01)

Vaccination Status and In-hospital Mortality Among Adults With COVID-19 in Jakarta, Indonesia: A Retrospective Hospital-based Cohort Study
by: Hotma Martogi Lorensi Hutapea, et al.
Published: (2023-11-01)

Modeling the dynamics of COVID-19 in the presence of Delta and Omicron variants with vaccination and non-pharmaceutical interventions
by: Shikha Saha, et al.
Published: (2023-07-01)

Insight into Delta variant dominated second wave of COVID-19 in Nepal
by: Khagendra Adhikari, et al.
Published: (2022-12-01)

Real-world effectiveness of full and booster mRNA vaccination for coronavirus disease 2019 against disease severity during the delta- and omicron-dominant phases: A propensity score-matched cohort study using the nationwide registry data in Japan
by: Tetsuya Suzuki, et al.
Published: (2024-02-01)

The Delta and Omicron Variants of SARS-CoV-2: What We Know So Far
by: Vivek P. Chavda, et al.
Published: (2022-11-01)

Covid-19 pandemic- A global concern
by: Md. Zaforullah Chowdhury
Published: (2022-04-01)

Real-World Effectiveness of Four Types of COVID-19 Vaccines
by: Derar H. Abdel-Qader, et al.
Published: (2023-05-01)

Intramuscular injection of a mixture of COVID-19 peptide vaccine and tetanus vaccine in horse induced neutralizing antibodies against authentic virus of SARS-CoV-2 Delta variant
by: Weiwen Deng, et al.
Published: (2022-12-01)

Association Between mRNA Vaccination and Infection From SARS-CoV-2 During the Delta and Omicron BA.1 Waves: A Population-Level Analysis
by: Allison P. Plaxco, MPH, et al.
Published: (2023-12-01)

Booster Vaccination Decreases 28-Day All-Cause Mortality of the Elderly Hospitalized Due to SARS-CoV-2 Delta Variant
by: Veronika Müller, et al.
Published: (2022-06-01)

Antibody Response of BNT162b2 and CoronaVac Platforms in Recovered Individuals Previously Infected by COVID-19 against SARS-CoV-2 Wild Type and Delta Variant
by: Ruiqi Zhang, et al.
Published: (2021-12-01)

Association between COVID-19 Vaccination and SARS-CoV-2 Infection among Household Contacts of Infected Individuals: A Prospective Household Study in England
by: Khitam Muhsen, et al.
Published: (2024-01-01)

Genomic Characterisation and Epidemiology of XBB Recombinant Variant of Severe Acute Respiratory Syndrome Coronavirus 2 in Uttarakhand using Next Generation Sequencing: A Retrospective Cross-sectional Study
by: Shekhar Pal, et al.
Published: (2024-04-01)

Clinical Characterization and Genomic Analysis of Samples from COVID-19 Breakthrough Infections during the Second Wave among the Various States of India
by: Nivedita Gupta, et al.
Published: (2021-09-01)

Active viral shedding in a vaccinated hospitalized patient infected with the delta variant (B.1.617.2) of SARS-CoV-2 and challenges of de-isolation
by: Abeer N. Alshukairi, et al.
Published: (2022-06-01)

A global analysis of COVID-19 infection fatality rate and its associated factors during the Delta and Omicron variant periods: an ecological study
by: Nhi Thi Hong Nguyen, et al.
Published: (2023-06-01)

Differences in Long-COVID Symptoms between Vaccinated and Non-Vaccinated (BNT162b2 Vaccine) Hospitalized COVID-19 Survivors Infected with the Delta Variant
by: César Fernández-de-las-Peñas, et al.
Published: (2022-09-01)

Modeling the Impact of Vaccination on COVID-19 and Its Delta and Omicron Variants
by: Jianbo Wang, et al.
Published: (2022-07-01)

mRNA vaccine effectiveness against SARS-CoV-2 B.1.617.2 (Delta) and B.1.1.529 (Omicron) variant transmission from home care cases to household contacts in South Korea
by: Hanul Park, et al.
Published: (2022-12-01)

Vaccine Breakthrough Infections by SARS-CoV-2 Variants after ChAdOx1 nCoV-19 Vaccination in Healthcare Workers
by: Pratibha Kale, et al.
Published: (2021-12-01)

COVID-19 vaccination effectiveness in the population of Friuli Venezia Giulia, North-East Italy. Control of bias associated with divergent compliance to policies in a test-negative case-control study
by: Valentina Rosolen, et al.
Published: (2023-12-01)

Confirmed Delta Variant COVID-19 Infection at A Single Centre Tertiary Hospital: A Case Series
by: Sally Aman Nasution, et al.
Published: (2022-04-01)

Fast-track development of vaccines for SARS-CoV-2: The shots that saved the world
by: Vivek P. Chavda, et al.
Published: (2022-10-01)

COVID-19 in India: Epidemiological reflections from initial 170 million consecutive test results
by: Rohan Lohia, et al.
Published: (2022-10-01)

COVID-19 Recovery Patterns Across Alpha (B.1.1.7) and Delta (B.1.617.2) Variants of SARS-CoV-2
by: Nitya Kumar, et al.
Published: (2022-02-01)

Editorial. La variante delta del COVID-19: ¿qué podemos esperar?
by: Javier Hernández Fernández
Published: (2021-07-01)

Development of Receptor Binding Domain (RBD)‐Conjugated Nanoparticle Vaccines with Broad Neutralization against SARS‐CoV‐2 Delta and Other Variants
by: Ran Chen, et al.
Published: (2022-04-01)

Effectiveness of Inactivated COVID-19 Vaccines against Delta-Variant COVID-19: Evidence from an Outbreak in Inner Mongolia Autonomous Region, China
by: Chao Ma, et al.
Published: (2023-01-01)

Effectiveness and Waning of Protection With Different SARS-CoV-2 Primary and Booster Vaccines During the Delta Pandemic Wave in 2021 in Hungary (HUN-VE 3 Study)
by: Zoltán Vokó, et al.
Published: (2022-07-01)

Comparative effectiveness of the sars-CoV-2 vaccines during delta dominance
by: Nazmul Islam, et al.
Published: (2023-05-01)

Neutralizing Activity Against SARS-CoV-2 Delta and Omicron Variants Following a Third BNT162b2 Booster Dose According to Three Homologous or Heterologous COVID-19 Vaccination Schedules
by: Ju-yeon Choi, et al.
Published: (2022-07-01)

Humoral Response in Hemodialysis Patients Following COVID-19 Vaccination and Breakthrough Infections during Delta and Omicron Variant Predominance
by: Rajkumar Chinnadurai, et al.
Published: (2022-03-01)

Willingness to vaccinate among adults, and factors associated with vaccine acceptance of COVID-19 vaccines in a nationwide study in Poland between March 2021 and April 2022
by: Eftychia Kotronia, et al.
Published: (2023-12-01)

Role of COVID-19 Vaccines in SARS-CoV-2 Variants
by: Zhou Zhou, et al.
Published: (2022-05-01)

Characteristics and outcomes of vaccinated and nonvaccinated patients hospitalized in a single Italian hub for COVID-19 during the Delta and Omicron waves in Northern Italy
by: Francesca Rovida, et al.
Published: (2022-09-01)

SARS-CoV-2 Vaccine Breakthrough Infections of Omicron and Delta Variants in Healthcare Workers
by: Elisa Regenhardt, et al.
Published: (2023-05-01)

Comparing real-life effectiveness of various COVID-19 vaccine regimens during the delta variant-dominant pandemic: a test-negative case-control study
by: Paskorn Sritipsukho, et al.
Published: (2022-12-01)

Comparison of COVID-19 Resilience Index and Its Associated Factors across 29 Countries during the Delta and Omicron Variant Periods
by: Le Duc Huy, et al.
Published: (2022-06-01)

Measuring the Effectiveness of COVID-19 Vaccines Used during a Surge of the Delta Variant of SARS-CoV-2 in Bangladesh: A Test-Negative Design Evaluation
by: Farhana Khanam, et al.
Published: (2022-12-01)